Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2026

Upper GI Pathology

Barrett’s esophagus and associated neoplasia, inflammatory conditions, gastric polyps and precursor lesions.

Celiac Disease

Diagnostic criteria, differential diagnosis and practical biopsy interpretation of celiac and related disorders.

IBD & Colitis

Biopsy diagnosis of colitis, IBD controversies, infectious disorders and practical differential diagnosis.

Colorectal Neoplasia

Colon polyps, polyposis, cancer staging and diagnostic challenges in colorectal specimens.

Mesenchymal & Lymphoid Tumors

GIST, non-GIST mesenchymal lesions, GI lymphomas and endocrine tumors of the tubular gut.

Molecular Diagnostics

Ancillary molecular testing in GI tract malignancies and integration of biomarkers into diagnostic workups.

Pancreaticobiliary Pathology

Cytology and small biopsies, pancreatic tumors, gallbladder pathology and biliary tract disease.

Medical Liver Pathology

Acute hepatitis, porto-sinusoidal vascular disease, autoimmune hepatitis and cholestatic disorders.

Hepatic Tumors

Hepatocellular carcinoma and mimickers, morphology, differential diagnosis and clinically relevant interpretation.

Access the recorded 2026 pathology program. 3 days • GI pathology • pancreaticobiliary disease • liver pathology • case-based learning

Learning Objectives

Strengthen morphology-based diagnosis while using ancillary testing, staging systems and biomarkers more appropriately in daily practice.

• Apply systematic approaches to GI biopsy and resection specimens.
• Recognize newly described and evolving gastrointestinal entities.
• Improve differential diagnosis of inflammatory GI disorders.
• Evaluate pre-neoplastic lesions and colorectal neoplasia.
• Use ancillary molecular and immunohistochemical testing appropriately.
• Recognize major GI mesenchymal, lymphoid and neuroendocrine tumors.
• Improve pancreatic and biliary tumor interpretation.
• Apply practical pattern-based approaches to liver biopsy diagnosis.
• Recognize common and uncommon hepatic tumors.
• Use grading and staging systems with appropriate limitations in mind.

Course Leadership

The official program is directed by gastrointestinal pathologists from Massachusetts General Hospital and Brigham and Women’s Hospital.

Jonathan N. Glickman, MD, PhD

Associate Professor of Pathology Harvard Medical School Subspecialty Head, Gastrointestinal Pathology Massachusetts General Hospital

Mark Redston, MD

Associate Professor of Pathology Harvard Medical School Director of Gastrointestinal Pathology Brigham and Women’s Hospital

Complete 2026 Curriculum

Who Should Take This Course?

Gastrointestinal Pathologists Surgical Pathologists Hepatopathologists Pancreaticobiliary Pathologists Academic Pathologists Community Pathologists Gastroenterologists Pathology Residents Pathology Fellows Laboratory Professionals

Your Course Package

Pathology • GI • Liver • Pancreas • 2026

Review biopsy interpretation, inflammatory disease, neoplasia, molecular diagnostics, pancreaticobiliary pathology and liver pathology through the recorded three-day 2026 program.

Which layout would you like to use?

Flexbox Grid

Select your structure

Select your structure

Direction Column Direction Row

Select your structure

Recorded, on-demand educational materials with lifetime access. Access instructions are provided after successful payment.

Get Medical Courses is an independent seller of recorded educational materials. Faculty affiliations do not imply endorsement. Purchase does not include registration for the original live event, live participation, CME/CE credits or an official course certificate.